Abstract: The present invention relates to novel human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: An electronic battery tester for testing a storage battery in an automotive vehicle includes first test circuitry configured to couple to the storage battery, apply a forcing function to the storage battery, measure a response of the storage battery to the applied forcing function and provide a battery test output related to a condition of the battery based upon the response of the battery to the applied forcing function. Starter voltage measurement circuitry electrically couples to a starter motor of the automotive vehicle and collects starter voltage profile information comprising a plurality of starter voltage measurements obtained at different times while operating the starter motor. Second test circuitry receives the battery test output from the first test circuitry and the starter voltage profile information and provides an enhanced battery test output related to the condition of the battery based upon the battery test output and the starter voltage profile information.

Abstract: The present invention relates to human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: A staging engine of a staging server receives a request to change a production database from a client device. The staging engine of the staging server accesses one or more schemas corresponding to the production database and determines one or more migration commands based on the received request and the accessed one or more schemas. The one or more migration commands correspond to a difference between a current structure of the production database and a final structure of the production database after the production database is updated. The staging engine transmits the one or more migration commands to a migration engine, wherein the migration engine asynchronously applies changes to the production database according to the one or more migration commands.

Abstract: Multispecific, human heavy chain antibodies (e.g., UniAbs™) that have modified heavy chain constant regions that impart advantageous properties are provided. The invention further concerns methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by expression of one or more of the binding targets described herein.

Abstract: The present invention relates to novel human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: The present invention relates to human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: The present invention relates to human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: Multispecific, human heavy chain antibodies (e.g., UniAbs™) that have modified heavy chain constant regions that impart advantageous properties are provided. The invention further concerns methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by expression of one or more of the binding targets described herein.

Abstract: The present invention relates to human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: Multispecific, human heavy chain antibodies (e.g., UniAbs™) that have modified heavy chain constant regions that impart advantageous properties are provided. The invention further concerns methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by expression of one or more of the binding targets described herein.

Abstract: A staging engine of a staging server receives a request to change a production database from a client device. The staging engine of the staging server accesses one or more schemas corresponding to the production database and determines one or more migration commands based on the received request and the accessed one or more schemas. The one or more migration commands correspond to a difference between a current structure of the production database and a final structure of the production database after the production database is updated. The staging engine transmits the one or more migration commands to a migration engine, wherein the migration engine asynchronously applies changes to the production database according to the one or more migration commands.

Abstract: Multispecific, human heavy chain antibodies (e.g., UniAbs™) that have modified heavy chain constant regions that impart advantageous properties are provided. The invention further concerns methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by expression of one or more of the binding targets described herein.

Abstract: A staging engine of a staging server receives a request to change a production database from a client device. The staging engine of the staging server accesses one or more schemas corresponding to the production database and determines one or more migration commands based on the received request and the accessed one or more schemas. The one or more migration commands correspond to a difference between a current structure of the production database and a final structure of the production database after the production database is updated. The staging engine transmits the one or more migration commands to a migration engine, wherein the migration engine asynchronously applies changes to the production database according to the one or more migration commands.

Abstract: The present invention relates to novel human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: Multispecific, human heavy chain antibodies (e.g., UniAbs™) that have modified heavy chain constant regions that impart advantageous properties are provided. The invention further concerns methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by expression of one or more of the binding targets described herein.

Abstract: Multispecific, human heavy chain antibodies (e.g., UniAbs™) that have modified heavy chain constant regions that impart advantageous properties are provided. The invention further concerns methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat disorders that are characterized by expression of one or more of the binding targets described herein.

Abstract: A staging engine of a staging server receives a request to change a production database from a client device. The staging engine of the staging server accesses one or more schemas corresponding to the production database and determines one or more migration commands based on the received request and the accessed one or more schemas. The one or more migration commands correspond to a difference between a current structure of the production database and a final structure of the production database after the production database is updated. The staging engine transmits the one or more migration commands to a migration engine, wherein the migration engine asynchronously applies changes to the production database according to the one or more migration commands.

Abstract: The present invention relates to novel human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.

Abstract: The present invention relates to novel human CD3 antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bispecific antibody molecules capable of activating immune effector cells and their use in diagnosis and/or treatment of various diseases.